Profit taking weighs down Rosetta Genomics
February 18, 2015 at 11:43 AM EST
Profit taking weighed down shares of Rosetta Genomics Ltd. (Nasdaq: ROSG) 96 cents to $3.84.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.